Literature DB >> 29977546

Surgical outcome of extended liver resections for colorectal liver metastasis compared with standard liver resections.

Go Shinke1, Takehiro Noda1, Hidetoshi Eguchi1, Yoshifumi Iwagami1, Daisaku Yamada1, Tadafumi Asaoka1, Koichi Kawamoto1, Kunihito Gotoh1, Shogo Kobayashi1, Yutaka Takeda1,2, Masahiro Tanemura1,3, Tsunekazu Mizushima1, Koji Umeshita4, Yuichiro Doki1, Masaki Mori1.   

Abstract

Colorectal liver metastatic lesions sometimes invade adjacent organs. A hepatectomy is often extended to include the involved adjacent organ to achieve negative surgical margins. The purpose of the present retrospective study was to evaluate the surgical outcomes of extended liver resections and patients' prognoses. The medical records of 178 patients with colorectal liver metastasis who underwent liver resections in the Department of Gastroenterological Surgery at Osaka University Hospital (Suita, Japan), from 2000 to 2015 were reviewed. These patients were divided into two groups: the extended resection group (n=20) and the non-extended resection group (n=158). The disease-free and overall survival curves were estimated with the Kaplan-Meier method and analyzed with the log rank test. It was observed that the extended resection group had longer operation times and increased blood loss, however perioperative morbidity was similar. The organs resected most frequently were the diaphragm (n=10) and inferior vena cava (n=5). Overall survival rates in the extended resection group were lower compared with the non-extended resection group (5-year survival rates; 45.0 vs. 67.9%), however the difference was not significant. It was indicated that the aggressive hepatectomy combined with resection of adjacent organs was an acceptable treatment with low perioperative morbidity. The overall survival rate may not be inferior to that of simple hepatectomy.

Entities:  

Keywords:  colon cancer; diaphragm; hepatectomy; inferior vena cava; liver cancer

Year:  2018        PMID: 29977546      PMCID: PMC6031016          DOI: 10.3892/mco.2018.1632

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  26 in total

1.  Combined liver and inferior vena cava resection for hepatic malignancy.

Authors:  Spiros G Delis; Juan Madariaga; Gaetano Ciancio
Journal:  J Surg Oncol       Date:  2007-09-01       Impact factor: 3.454

2.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Authors:  Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

Review 3.  Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience.

Authors:  Stefan Stättner; Florian Primavesi; Vincent S Yip; Robert P Jones; Dietmar Öfner; Hassan Z Malik; Stephen W Fenwick; Graeme J Poston
Journal:  Surg Today       Date:  2014-03-16       Impact factor: 2.549

4.  Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.

Authors:  Nancy Kemeny; William Jarnagin; Philip Paty; Mithat Gönen; Lawrence Schwartz; Meroë Morse; Gregory Leonard; Michael D'Angelica; Ronald DeMatteo; Leslie Blumgart; Yuman Fong
Journal:  J Clin Oncol       Date:  2005-07-11       Impact factor: 44.544

5.  Our technique of preceding diaphragm resection and partial mobilization of the hepatic right lobe using a vessel sealing device (LigaSure™) for huge hepatic tumors with diaphragm invasion.

Authors:  Kenji Wakayama; Toshiya Kamiyama; Hideki Yokoo; Tatsuhiko Kakisaka; Tatsuya Orimo; Shingo Shimada; Yosuke Tsuruga; Hirofumi Kamachi; Akinobu Taketomi
Journal:  Surg Today       Date:  2016-01-19       Impact factor: 2.549

6.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

7.  Inferior vena cava resection with hepatectomy: challenging but justified.

Authors:  Deep J Malde; Aamir Khan; K Rajendra Prasad; Giles J Toogood; J Peter A Lodge
Journal:  HPB (Oxford)       Date:  2011-09-16       Impact factor: 3.647

8.  Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer.

Authors:  Taku Aoki; Yasuhiko Sugawara; Hiroshi Imamura; Yasuji Seyama; Masami Minagawa; Kiyoshi Hasegawa; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  J Am Coll Surg       Date:  2004-03       Impact factor: 6.113

9.  Factors influencing the natural history of colorectal liver metastases.

Authors:  R Stangl; A Altendorf-Hofmann; R M Charnley; J Scheele
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

10.  A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation.

Authors:  S Cascinu; R Berardi; S Salvagni; G D Beretta; V Catalano; F Pucci; A Sobrero; P Tagliaferri; R Labianca; M Scartozzi; F Crocicchio; E Mari; A Ardizzoni
Journal:  Br J Cancer       Date:  2007-12-04       Impact factor: 7.640

View more
  5 in total

1.  Current trends in vena cava reconstructive techniques with major liver resection: a systematic review.

Authors:  Maria Baimas-George; Christoph Tschuor; Michael Watson; Jesse Sulzer; Patrick Salibi; David Iannitti; John B Martinie; Erin Baker; Pierre-Alain Clavien; Dionisios Vrochides
Journal:  Langenbecks Arch Surg       Date:  2020-09-26       Impact factor: 3.445

Review 2.  The impact of multivisceral liver resection on short- and long-term outcomes of patients with colorectal liver metastasis: A systematic review and meta-analysis.

Authors:  Sérgio Silveira Júnior; Francisco Tustumi; Daniel de Paiva Magalhães; Vagner Birk Jeismann; Gilton Marques Fonseca; Jaime Arthur Pirola Kruger; Fabricio Ferreira Coelho; Paulo Herman
Journal:  Clinics (Sao Paulo)       Date:  2022-09-16       Impact factor: 2.898

3.  Chemotherapy and Hepatic Steatosis: Impact on Postoperative Morbidity and Survival after Liver Resection for Colorectal Liver Metastases.

Authors:  Jan C Mahlmann; Thomas C Wirth; Björn Hartleben; Harald Schrem; Jens F Mahlmann; Alexander Kaltenborn; Jürgen Klempnauer; Ulf Kulik
Journal:  Visc Med       Date:  2020-10-09

4.  Laparoscopic liver resection with simultaneous diaphragm resection.

Authors:  Airazat M Kazaryan; Davit L Aghayan; Åsmund A Fretland; Vasiliy I Semikov; Alexander M Shulutko; Bjørn Edwin
Journal:  Ann Transl Med       Date:  2020-03

5.  Pringle Maneuver in Extended Liver Resection: A propensity score analysis.

Authors:  Mohammed Al-Saeedi; Omid Ghamarnejad; Elias Khajeh; Saeed Shafiei; Roozbeh Salehpour; Mohammad Golriz; Markus Mieth; Karl Heinz Weiss; Thomas Longerich; Katrin Hoffmann; Markus W Büchler; Arianeb Mehrabi
Journal:  Sci Rep       Date:  2020-06-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.